Oncology care is becoming more complex every day, offering hope to patients, but bringing challenges to clinicians who need access to the latest and most accurate data. Collaboration and shared standards are essential for ensuring that the industry can maximize the potential of precision medicine.
We spoke with Vivien about the regimen workflow process at Flatiron, how OncoEMR is designed from a clinician’s point of view, and more.
Precision medicine unlocks access to standard of care and experimental therapies with the promise of improving outcomes and advancing cancer care for everyone.
Community oncology plays a critical role in improving clinical trial accessibility. In this panel you'll hear from clinical research leaders who are making clinical trials more accessible and inclusive, including practical takeaways for research programs.
We spoke with Dr. Iuliana Shapira about how COVID affected her practice, the way the government gets involved in electronic health records and the advice she has for us on improving CareSpace.
We spoke with Dr. Ted Arrowsmith about the benefits of centrally managed regimens, the difference between OncoEMR® and hospital systems, the dream of robust decision support and more.